Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women

NCT00344032 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

354

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Papillomavirus

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: HPV-16/18 VLP/AS04 Vaccine (Cervarix TM)

Sponsor

GlaxoSmithKline